We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 4,444 results
  1. [18F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data

    Objectives

    Reactive gliosis is a common pathological hallmark of CNS pathology resulting from neurodegeneration and neuroinflammation. In this study...

    Anna Ballweg, Carolin Klaus, ... Matthias Brendel in Journal of Neuroinflammation
    Article Open access 11 March 2023
  2. A Novel Eyes Topical Drug Delivery System: CsA-LNC for the Treatment of DED

    Purpose

    The objective of the present work was to prepare safe and effective Ciclosporin A Lipid nanocapsule (CsA-LNC) eye-drops for the treatment of...

    Anan Zhang, Rong Sun, ... **ng Tang in Pharmaceutical Research
    Article 14 July 2020
  3. Aurantio-obtusin Alleviates Dry Eye Disease by Targeting NF-κB/NLRP3 Signaling in Rodent Models

    Dry eye disease (DED) is a common inflammatory ocular surface disorder, seriously affecting the quality of life of patients. Aurantio-obtusin (AO) is...

    Dan Zhu, Na Zheng, ... Liangchang Li in Biochemical Genetics
    Article 26 August 2023
  4. DZ2002 alleviates corneal angiogenesis and inflammation in rodent models of dry eye disease via regulating STAT3-PI3K-Akt-NF-κB pathway

    Dry eye disease (DED) is a prevalent ocular disorder with a multifactorial etiology. The pre-angiogenic and pre-inflammatory milieu of the ocular...

    Chun-mei Wu, Jia-wen Mao, ... Jian-** Zuo in Acta Pharmacologica Sinica
    Article 21 August 2023
  5. Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP

    Background

    Plasma assays for the detection of Alzheimer’s disease neuropathological changes are receiving ever increasing interest. The concentration...

    Konstantinos Chiotis, Charlotte Johansson, ... Agneta Nordberg in Molecular Neurodegeneration
    Article Open access 12 September 2023
  6. Interleukin-20 is involved in dry eye disease and is a potential therapeutic target

    Background

    Dry eye disease (DED) is a common disease in ophthalmology, affecting millions of people worldwide. Recent studies have shown that...

    Hsiao-Hsuan Wang, Wei-Yu Chen, ... Ming-Shi Chang in Journal of Biomedical Science
    Article Open access 09 June 2022
  7. Is the Sex Difference a Clue to the Pathomechanism of Dry Eye Disease? Watch out for the NGF-TrkA-Piezo2 Signaling Axis and the Piezo2 Channelopathy

    Dry eye disease (DED) is a multifactorial disorder with recognized pathology, but not entirely known pathomechanism. It is suggested to represent a...

    Balázs Sonkodi, Miklós D. Resch, Tibor Hortobágyi in Journal of Molecular Neuroscience
    Article Open access 04 May 2022
  8. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach

    The recent progress in the development of in vivo biomarkers is rapidly changing how neurodegenerative diseases are conceptualized and diagnosed and...
    Elena Rodriguez-Vieitez, Amit Kumar, ... Konstantinos Chiotis in Biomarkers for Alzheimer’s Disease Drug Development
    Protocol 2024
  9. Targeting purinergic receptors to attenuate inflammation of dry eye

    Inflammation is one of the potential factors to cause the damage of ocular surface in dry eye disease (DED). Increasing evidence indicated that...

    Jia-Ning Wang, Hua Fan, Jian-Tao Song in Purinergic Signalling
    Article Open access 26 February 2022
  10. Prolonged Release Niosomes For Ocular Delivery of Loteprednol: Ocular Distribution Assessment on Dry Eye Disease Induced Rabbit Model

    Loteprednol etabonate (LE) is a topical corticosteroid for the symptomatic management of ocular conditions, encompassing both allergic and infectious...

    Samet Ozdemir, Burcu Uner in AAPS PharmSciTech
    Article 30 May 2024
  11. Capsazepine decreases corneal pain syndrome in severe dry eye disease

    Background

    Dry eye disease (DED) is a multifactorial disease of the ocular surface accompanied by neurosensory abnormalities. Here, we evaluated the...

    Darine Fakih, Adrian Guerrero-Moreno, ... Stéphane Mélik Parsadaniantz in Journal of Neuroinflammation
    Article Open access 11 May 2021
  12. A Survey on How Ocular Surface Demodex Infestation Interactively Associates with Diabetes Mellitus and Dry Eye Disease

    Purpose

    Prevention of ocular surface (OS) Demodex infestation plays an important role in OS hygiene and variety of factors may be associated with it,...

    Chang Huang, Shuze Chen, ... Min Fu in Acta Parasitologica
    Article Open access 03 April 2021
  13. The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4/NF-κB/NLRP3 signaling

    Dry eye disease (DED) is a multifactorial disorder of the tears and ocular surface characterized by manifestations of dryness and irritation....

    Fang-ming Yang, Di Fan, ... Jian-** Zuo in Acta Pharmacologica Sinica
    Article 03 August 2020
  14. Association between dietary energy density with mental health and sleep quality in women with overweight/obesity

    Objective

    Mental health, sleep quality, and dietary intake are interlinked. Impairment of mental health and low sleep quality may contribute to...

    Niloofar Sadat Maddahi, Habib Yarizadeh, ... Khadijeh Mirzaei in BMC Research Notes
    Article Open access 30 March 2020
  15. The functions of IL-23 and IL-2 on driving autoimmune effector T-helper 17 cells into the memory pool in dry eye disease

    Long-lived memory T-helper 17 (Th17) cells actively mediate the chronic inflammation in autoimmune disorders, including dry eye disease (DED). The...

    Yihe Chen, Chunyi Shao, ... Reza Dana in Mucosal Immunology
    Article 23 April 2020
  16. Potential Applications and Additive Manufacturing Technology-Based Considerations of Mesoporous Silica: A Review

    Nanoporous materials are categorized as microporous (pore sizes 0.2–2 nm), mesoporous (pore sizes 2–50 nm), and macroporous (pore sizes 50–1000 nm)....

    Jigar Vyas, Sudarshan Singh, ... Bhupendra G. Prajapati in AAPS PharmSciTech
    Article 21 December 2023
  17. Chronic dry eye induced corneal hypersensitivity, neuroinflammatory responses, and synaptic plasticity in the mouse trigeminal brainstem

    Background

    Dry eye disease (DED) is a multifactorial disease associated with ocular surface inflammation, pain, and nerve abnormalities. We studied...

    Darine Fakih, Zhanlin Zhao, ... Annabelle Réaux-Le Goazigo in Journal of Neuroinflammation
    Article Open access 17 December 2019
  18. Circadian disruption reduces MUC4 expression via the clock molecule BMAL1 during dry eye development

    Circadian disruption, as a result of shiftwork, jet lag, and other lifestyle factors, is a common public health problem associated with a wide range...

    Hao Zeng, Xue Yang, ... ** Yuan in Experimental & Molecular Medicine
    Article Open access 02 July 2024
  19. Shedding Valuable Tears: Tear Fluid as a Promising Source of Disease Biomarkers

    Abstract

    The simplicity of collecting and evaluating tear fluid (TF) can potentially provide a convenient non-invasive diagnostic tool that easily...

    Ia. S. Vavilina, A. A. Shpak, ... N. V. Gulyaeva in Neurochemical Journal
    Article 01 December 2023
  20. Relationship Between Reactive Astrocytes, by [18F]SMBT-1 Imaging, with Amyloid-Beta, Tau, Glucose Metabolism, and TSPO in Mouse Models of Alzheimer’s Disease

    Reactive astrocytes play an important role in the development of Alzheimer’s disease (AD). Here, we aimed to investigate the temporospatial...

    Yanyan Kong, Cinzia A. Maschio, ... Ruiqing Ni in Molecular Neurobiology
    Article Open access 19 March 2024
Did you find what you were looking for? Share feedback.